 |
|
ASCPT 2026 Early Bird Registration Ends on January 30, 2026!
Early bird registration for the ASCPT 2026 Annual Meeting ends Friday, January 30, 2026. After that, rates go up, so don’t delay committing to the one place where quantitative, translational, and clinical pharmacology thinking converges across the entire drug discovery, development, regulation, and utilization continuum. Click here to register today. |
 |
|
THURSDAY, JANUARY 15, 2026, 2:00 PM
Visit with Visser
Connect directly with ASCPT President, Sandra A.G. Visser, PhD, and engage with fellow colleagues in a dynamic, interactive setting. This unique opportunity allows you to share insights, discuss the latest in clinical pharmacology, and build meaningful professional connections within the ASCPT community. |
 |
|
TUESDAY, JANUARY 20, 2026, 2:00 PM ET
Pharmaco-Inequity in Focus: Discussion with Global Experts on Evidence and Action
This session will highlight strategies to advance pharmacoequity-the principle that everyone, regardless of background or location, should have equitable access to the medicines they need. |
 |
|
THURSDAY, JANUARY 22, 12:00 PM ET
Exposure- Response- Based Multi-Attribute Clinical Utility Score Framework to Facilitate Optimal Dose Selection for Oncology Drugs This webinar introduces the Exposure–Response (E–R)–based Clinical Utility Score (CUS) Framework, a novel quantitative approach designed to support optimal dose selection for oncology drugs. |
 |
|
MONDAY, JANUARY 26, 2026, 2:30 PM ET
Next-Generation CAR T Cell Development: Integrating Clinical Pharmacology and MIDD Approaches This webinar will deliver an integrated overview of the emerging CAR T landscape, highlighting the benefits, limitations, and key development considerations for allogeneic and in vivo–engineered modalities. |
 |
|
WEDNESDAY, JANUARY 28, 12:00 PM ET
Navigating First-in-Human Trials: Regulatory Feedback, Common Pitfalls, and Clinical Pharmacology Solutions
This session will explore insights from a clinical research expert who will discuss innovative strategies to effectively navigate the complexities of first-in-human (FIH) trials. |
|
 |
|
THURSDAY, FEBRUARY 5, 2026, 10:00 AM- 2:00 PM ET
What Does That Term Actually Mean? Demystifying Concepts in Quantitative Drug Development
Jackson Burton, PhD, and Stacey Tannenbaum, PhD, will lead a focused virtual workshop designed to clarify concepts in quantitative drug development and show how they’re applied in practice. This session provides a structured look at five emerging concepts, their role in modern drug development, and how experts are using them today. Click here to register. |
 |
|
COMING SOON: ASCPT CENTRAL!
We have exciting news! Later this month, we will officially launch our new integrated community platform, ASCPT Central! Once launched, members will gain a centralized, mobile-friendly hub to connect, collaborate, and innovate. Members will be empowered to engage in real-time discussions, access curated resources, and build professional networks through personalized feeds and event tools. Stay tuned for more information! |
 |
|
Open Calls for Papers at CPT!
Clinical Pharmacology & Therapeutics (CPT) has two new calls for papers open: "Advances in New Approach Methodologies (NAMs): From Bench Development and Validation to Regulatory Adoption" and "Advancing Therapeutics for Understudied Patient Groups." The calls close on May 15, 2026, and June 30, 2026, respectively, so be sure to check out the details and see if you have research that fits these themes. Click here to find more information on both these and other ASCPT Journal Family calls for papers. |
 |
|
Do You Have Fellowship or Internship Positions to Fill in the New Year?
Make sure you are using the ASCPT Career Center to help you source top candidates at an affordable price. Fellowship/Internship job posts are available for a nominal fee of $150 for ASCPT members. Click here to visit today |